Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Healthcare Plans

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Revenue projections:

Revenue projections for ELV
Revenue projections for ELV

ELV's revenue is forecasted to dip below last year's figures, raising concerns for investors who are typically wary of declining financial performance. Such drops can directly affect the company's bottom line, potentially leading to a decrease in overall profitability, making investors more cautious in their decisions.

Financial Ratios:

currentRatio 1.479000
forwardPE 13.494829
debtToEquity 72.299000
earningsGrowth -0.168000
revenueGrowth 0.026000
grossMargins 0.258910
operatingMargins 0.053030
trailingEps 23.600000
forwardEps 29.247500

A current ratio of 1.479 for ELV implies that the company has ample liquidity to meet its short-term debts. ELV's cash reserves and current assets should easily cover these obligations, highlighting its financial stability and ability to manage short-term liabilities.
Elevance Health, Inc.'s Forward PE is positioned well, reflecting a favorable balance between stock price and earnings. The stock isn't overpriced, offering room for growth and making it a potentially rewarding investment as its value has room to rise further.
ELV's low earnings and revenue growth suggest shrinking profits are likely. This could reflect broader financial struggles, signaling that the company might face difficulties in sustaining its profitability.
ELV's negative gross and operating margins suggest that the company is experiencing losses at both the production and operational levels. This could point to inefficiencies or declining demand for its products.
ELV's forward EPS surpasses its trailing EPS, reflecting expectations of higher profitability in the current year. This suggests that ELV is projected to generate stronger earnings, indicating an optimistic financial outlook compared to the prior year's results.

Price projections:

Price projections for ELV
Price projections for ELV

ELV's price has consistently hovered around the lower limit of price projections. This pattern suggests that the stock may be underperforming relative to expectations, which could lead to concerns among investors.

Insider Transactions:

Insider Transactions for ELV
Insider Transactions for ELV


There were 4 Elevance Health, Inc. sales transactions, at market price of 351.7038803100586.3 separate transactions to buy ELV were completed, while market price hovered around 291.27161661783856.The transactions conducted by insiders don't suggest any significant movement or clear trend, leaving the overall direction of the company uncertain.

Recommendation changes over time:

Recommendations trend for ELV
Recommendations trend for ELV


Analysts' buy bias toward Elevance Health, Inc. suggests the stock is seen as a solid investment, potentially motivating investors to consider it for their portfolios. With this positive outlook, Elevance Health, Inc. is likely to be viewed as a secure place to allocate funds, driving further interest in the stock.